Laboratory Filtration Market 2022 Future Growth Insights, Leading Players Update, Development & Opportunity
Laboratory Filtration Market Trends
The global laboratory filtration market is projected to reach USD 5.3 billion in 2026, from USD 3.6 billion in 2021, at a CAGR of 7.8% from 2021 to 2026. The growth of this market is mainly driven by increasing R&D spending in the pharmaceutical and biopharmaceutical sectors. industry. , increasing demand for membrane filtration technology, increasing purity demands in the end-user sector, and increasing interest in developing polymer biopharmaceuticals.
Get Sample PDF: https://www.marketsandmarkets.com/requestsampleNew.asp?id=12936082
Key Market Players of Laboratory Filtration Market
Merck Millipore (US), Danaher Corporation (US), Sartorius AG (Germany), 3M Company (US), GEA GROUP AKTIENGESELLSCHAFT (Germany), Steris (US), Thermo Fisher Scientific (US), Veolia Water Technologies (France), Avantor, Inc. (US), GVS S.p.A (Italy), MANN+HUMMEL (Germany), Agilent Technologies, Inc. (US)
Merck Millipore (US) is one of the prominent players in the global laboratory filtration market. The company is a supplier of lab materials, services, and technologies for the research, development, and production of pharmaceutical & biotechnology drug therapies. The company also has an extensive distribution channel across the globe. The company operates through three major segments—Healthcare, Life Science, and Performance Materials. The Life Science segment is subcategorized into Process Solutions, Research Solutions, and Applied Solutions.
COVID-19 impact on the Laboratory Filtration Market
COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic in just a matter of a few weeks. With the World Health Organization (WHO) officially declaring the outbreak of COVID-19 a pandemic, a mix of established pharmaceutical and biopharmaceutical companies, as well as small startups, have stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus.
The economic and social burden of the pandemic has prompted government bodies globally to increase support for vaccine development and manufacturing, which has led to an increase in the adoption of laboratory filtration products for COVID-19 research. Various filtration techniques are used in the development and production of vaccines. Clarification (removal of suspended matter from a fluid medium) of vaccines is a crucial step that impacts product recovery and subsequent downstream purification.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12936082
OPPORTUNITY: Advances in nanofiber technology
In pharmaceutical filtration, the newly developed nanofiber coating technology offers greater flexibility, control, and durability as compared to the traditional process of electrospinning. This new coating is made of fibers typically ranging from 0.3 to 0.5 microns in size, which can be increased to up to 1 micron. The fiber diameter distribution and layer thickness can easily be changed according to application requirements. The NANOWEB advanced nanofiber technology offers benefits in both air and liquid filtration and can be specifically designed to meet the stringent filtration requirements of many liquid applications. It also addresses the growing need for advanced microfiltration as well as reverse osmosis and ultrafiltration in a variety of liquid service applications, including life sciences, food & beverage, and process liquid filtration.
Recent Developments
- Koch Membrane Systems acquired Eco-Tec Inc. Eco-Tec offers resource-recovery and purification solutions to industries across the globe. This acquisition was aimed at expanding its existing capabilities in order to provide innovative ion exchange-based solutions.
- Sartorius Stedim Biotech collaborated with Novasep to develop novel systems for membrane chromatography.
Speak to our analyst for a discussion on the above findings: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=12936082
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian